Papers/PMID:23775705
Zinc for the common cold.
The Cochrane database of systematic reviews2013The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
Zn(2+) — increases adverse event occurrence (oral or enteral supplement)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Overall adverse events (OR 1.58, 95% CI 1.19 to 2.09) (P = 0.002), bad taste (OR 2.31, 95% CI 1.71 to 3.11) (P < 0.00001) and nausea (OR 2.15, 95% CI 1.44 to 3.23) (P = 0.002) were higher in the zinc group.”
Quoted verbatim from Zinc for the common cold.. - Study
- meta-analysis
- Population
- Participants in randomised double-blind placebo-controlled trials of zinc for treating or preventing the common cold, pooled across zinc formulations
Effect 1.58 odds ratio, 95% CI 1.19 to 2.09
Zinc for the common cold.2013PMID:23775705Permalink